puromycin drug
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Ascl1 | interacts_with | puromycin | — | 1 |
| puromycin | associated_with | hygromycin | — | 1 |
| puromycin | interacts_with | induced neurons | — | 1 |
Mentioned in (26)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- Enhancer activation from transposable elements in extrachromosomal DNA. (2025)
- FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. (2025)
- Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Functional analysis of cancer-associated germline risk variants. (2025)
- Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
- Single cell and spatial alternative splicing analysis with Nanopore long read sequencing. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- Biologically informed deep neural network for prostate cancer discovery. (2021)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. (2018)
- Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- A role for human homologous recombination factors in suppressing microhomology-mediated end joining. (2016)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
- Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| puromycin | drug | 38 | 68 |
| p8833 | drug | — | — |